<rss xmlns:a10="http://www.w3.org/2005/Atom" version="2.0"><channel><title>NIDDK Small Business Funding Opportunities</title><link>https://www.niddk.nih.gov/research-funding/current-opportunities?ac=sb</link><description>All small business funding opportunities currently available from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)</description><language>en</language><item><guid isPermaLink="false">{9E1A507C-E42E-437D-A323-18989BC108FE}</guid><link>https://www.niddk.nih.gov/research-funding/current-opportunities/not-od-24-079</link><title>Notice of Special Interest: Womens Health Research</title><description>In alignment with the White House Initiative on Women’s Health Research, the National Institutes of Health (NIH) is issuing this Notice of Special Interest to highlight interest in receiving research applications focused on diseases and health conditions that predominantly affect women (e.g., autoimmune diseases; depressive disorders, Alzheimer’s disease (AD) and Alzheimer’s disease-related dementias (ADRD), gender-based-violence), present and progress differently in women (e.g., cardiovascular disease; HIV; reproductive aging and its implications), or are female-specific (e.g., uterine fibroids; endometriosis; menopause).&lt;br/&gt;&lt;br/&gt;For consideration under this NOSI, applications must have a central focus on the health of women, as demonstrated through specific aims that EITHER explicitly address a particular condition in women OR focus on one of the high priority topics below. In either approach, intersectional and/or multidimensional approaches that consider the health of women in context (e.g., projects accounting for social and structural variables—including race, ethnicity, socioeconomic status , and State and Federal policies— that affect women’s health) are strongly encouraged. For consideration under this NOSI, projects are not required to exclusively focus on women. However, studies that include more than one sex or gender should be designed and powered to make generalizable conclusions about women and enable sex or gender difference comparison.</description><pubDate>Tue, 26 Mar 2024 00:00:00 -0400</pubDate></item><item><guid isPermaLink="false">{5DBEB765-7FAF-451F-A55E-32715FF89D37}</guid><link>https://www.niddk.nih.gov/research-funding/current-opportunities/rfa-md-24-006</link><title>Innovations for Healthy Living - Improving Minority Health and Eliminating Health Disparities (R43/R44 - Clinical Trial Optional)</title><description>This Notice of Funding Opportunity (NOFO) invites eligible United States small business concerns (SBCs) to submit Small Business Innovation Research (SBIR) grant applications that propose to develop a product, process or service for commercialization with the aim of improving minority health and/or reducing and ultimately eliminating health disparities in one or more populations that experience health disparities. Appropriate technologies should be effective, affordable, and culturally acceptable.</description><pubDate>Fri, 08 Mar 2024 15:00:09 -0500</pubDate></item><item><guid isPermaLink="false">{B0AC02DA-79A5-483F-92EB-3A22E1F581CC}</guid><link>https://www.niddk.nih.gov/research-funding/current-opportunities/not-dk-24-007</link><title>Notice of Special Interest (NOSI): Addressing Health Disparities and Advancing Health Equity in NIDDK Diseases</title><description>This NOSI invites applications for research to understand and mitigate health disparities in the prevention, development, diagnosis, treatment and progression of diseases and conditions of high priority to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). It is recognized that health disparities are driven by factors operating at multiple levels (i.e., individual, interpersonal, community, societal) and domains (e.g., biological, behavioral, sociocultural, physical/built environment, etc.) and interacting in complex ways. (Refer to the NIMHD Minority Health and Health Disparities Research Framework.)</description><pubDate>Wed, 20 Dec 2023 00:00:00 -0500</pubDate></item><item><guid isPermaLink="false">{C241B69D-87AE-45AD-82BD-52AED7C7A975}</guid><link>https://www.niddk.nih.gov/research-funding/current-opportunities/not-dk-23-015</link><title>Notice of Special Interest (NOSI): Next-Generation Approaches to Renal Replacement Therapy Including Vascular Access</title><description>This NOSI aims to support the development of innovative approaches to renal replacement therapy and address critical accompanying challenges such as vascular access and fluid management during dialysis. </description><pubDate>Mon, 14 Aug 2023 00:00:00 -0400</pubDate></item><item><guid isPermaLink="false">{B31BC606-0B65-4E70-A7E8-D82A6D1D6216}</guid><link>https://www.niddk.nih.gov/research-funding/current-opportunities/par-23-219</link><title>SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1, Clinical Trial Not Allowed)</title><description>The purpose of this Notice of Funding Opportunity (NOFO) is to encourage applications from small business concerns (SBCs) to the newly re-authorized Commercialization Readiness Pilot (CRP) program. The NOFO aims to facilitate the transition of previously or currently funded SBIR and STTR Phase II and Phase IIB projects to the commercialization stage by providing additional support for technical assistance and later stage research and development (R and D) not typically supported through Phase II or Phase IIB grants or contracts. This may include independent replication of key studies, Investigational New Drug (IND)-enabling studies, clinical studies, manufacturing costs, regulatory assistance, or a combination of services. Although a significant amount of the work in a CRP award may be subcontracted to other institutions, the Small Business Concern (SBC) is expected to maintain oversight and management of the R and D throughout the award.&lt;br/&gt;Clinical Trials are not accepted under this NOFO.</description><pubDate>Wed, 12 Jul 2023 14:28:32 -0400</pubDate></item></channel></rss>